Treace Medical Concepts (TMCI) Revenue & Revenue Breakdown
Treace Medical Concepts Revenue Highlights
Latest Revenue (Y)
$187.12M
Latest Revenue (Q)
$45.09M
Treace Medical Concepts Revenue by Period
Treace Medical Concepts Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $187.12M | 31.92% |
2022-12-31 | $141.84M | 50.22% |
2021-12-31 | $94.42M | 64.59% |
2020-12-31 | $57.37M | 45.54% |
2019-12-31 | $39.42M | - |
Treace Medical Concepts generated $187.12M in revenue during NA 2023, up 31.92% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Treace Medical Concepts Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $45.09M | 1.42% |
2024-06-30 | $44.45M | -13.02% |
2024-03-31 | $51.11M | -17.85% |
2023-12-31 | $62.21M | 52.64% |
2023-09-30 | $40.76M | -2.85% |
2023-06-30 | $41.95M | -0.57% |
2023-03-31 | $42.20M | -15.22% |
2022-12-31 | $49.77M | 50.56% |
2022-09-30 | $33.05M | 10.30% |
2022-06-30 | $29.97M | 3.17% |
2022-03-31 | $29.05M | -13.13% |
2021-12-31 | $33.44M | 54.67% |
2021-09-30 | $21.62M | 4.67% |
2021-06-30 | $20.65M | 10.41% |
2021-03-31 | $18.71M | -22.39% |
2020-12-31 | $24.11M | 68.97% |
2020-09-30 | $14.27M | 84.34% |
2020-06-30 | $7.74M | -31.25% |
2020-03-31 | $11.26M | - |
Treace Medical Concepts generated $45.09M in revenue during Q3 2024, up 1.42% compared to the previous quarter, and up 107.47% compared to the same period a year ago.
Treace Medical Concepts Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ITGR | Integer | $1.60B | $746.27M |
CNMD | CONMED | $1.24B | $316.70M |
LIVN | LivaNova | $1.15B | $318.11M |
TCMD | Tactile Systems | $274.42M | $73.09M |
FNA | Paragon 28 | $216.39M | $61.02M |
TMCI | Treace Medical Concepts | $187.12M | $45.09M |
ESTA | Establishment Labs | $165.15M | $40.23M |
AXGN | AxoGen | $159.01M | $48.64M |
KIDS | OrthoPediatrics | $148.73M | $52.80M |
SRDX | Surmodics | $126.08M | $29.92M |
RXST | RxSight | $89.08M | $45.41M |
SGHT | Sight Sciences | $81.06M | $20.16M |
LUNG | Pulmonx | $68.67M | $20.39M |
IRMD | IRadimed | $65.56M | $18.33M |
NPCE | NeuroPace | $65.42M | $21.06M |
OFIX | Orthofix Medical | $100.00K | $198.62M |